- Home
- WWW vs AGIO Comparison
WWW vs AGIO Comparison
Compare WWW & AGIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WWW
- AGIO
- Stock Information
- Founded
- WWW 1883
- AGIO 2007
- Country
- WWW United States
- AGIO United States
- Employees
- WWW N/A
- AGIO N/A
- Industry
- WWW Shoe Manufacturing
- AGIO Biotechnology: Pharmaceutical Preparations
- Sector
- WWW Consumer Discretionary
- AGIO Health Care
- Exchange
- WWW Nasdaq
- AGIO Nasdaq
- Market Cap
- WWW 2.5B
- AGIO 2.1B
- IPO Year
- WWW N/A
- AGIO 2013
- Fundamental
- Price
- WWW $30.67
- AGIO $36.42
- Analyst Decision
- WWW Buy
- AGIO Buy
- Analyst Count
- WWW 6
- AGIO 6
- Target Price
- WWW $29.67
- AGIO $57.00
- AVG Volume (30 Days)
- WWW 1.6M
- AGIO 762.4K
- Earning Date
- WWW 11-06-2025
- AGIO 10-30-2025
- Dividend Yield
- WWW 1.30%
- AGIO N/A
- EPS Growth
- WWW N/A
- AGIO N/A
- EPS
- WWW 1.04
- AGIO 11.13
- Revenue
- WWW $1,821,400,000.00
- AGIO $40,875,000.00
- Revenue This Year
- WWW $7.52
- AGIO $23.66
- Revenue Next Year
- WWW $6.57
- AGIO $143.65
- P/E Ratio
- WWW $29.63
- AGIO $3.35
- Revenue Growth
- WWW N/A
- AGIO 30.57
- 52 Week Low
- WWW $9.58
- AGIO $23.42
- 52 Week High
- WWW $32.80
- AGIO $62.58
- Technical
- Relative Strength Index (RSI)
- WWW 60.25
- AGIO 47.14
- Support Level
- WWW $29.37
- AGIO $35.72
- Resistance Level
- WWW $31.46
- AGIO $37.18
- Average True Range (ATR)
- WWW 0.95
- AGIO 1.58
- MACD
- WWW -0.46
- AGIO -0.14
- Stochastic Oscillator
- WWW 37.90
- AGIO 44.29
About WWW Wolverine World Wide Inc.
Wolverine World Wide Inc is engaged in designing, manufacturing, sourcing, marketing, licensing, and distributing branded footwear, apparel, and accessories. The company's segment includes Active Group; Work Group; Corporate and Other. It generates maximum revenue from the Active Group segment. Active Group segment consists of Merrell footwear and apparel, Saucony footwear and apparel, Sweaty Betty activewear, and Chaco footwear.
About AGIO Agios Pharmaceuticals Inc.
Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236, and others.